Recent regulatory changes, shrinking product pipelines and shorter patent windows have prompted the need for a high-value competitive intelligence function that can help bio-pharmaceutical organizations drive strategic decisions.
But the non-traditional competitive intelligence function is often undervalued in corporations, and competitive intelligence leaders often find themselves struggling for attention and resources.
Best Practices, LLC undertook benchmarking research to identify best practices and innovative methods for improving the strategic role and impact of the competitive intelligence function within the bio-pharmaceutical industry. In particular, this report provides benchmarks around the structure and leadership of the competitive intelligence function, key competitive intelligence sources and activities; resource levels, use of third party vendors and requisite employee competencies.
Competitive intelligence leaders can use this report to evaluate and compare the performance of their function against industry standards.